Neck lymph nodes in MS showed more Epstein-Barr virus

Credibility

Interest

Share:1 min read

Key Takeaway

People with newly diagnosed, untreated MS had more Epstein-Barr virus in neck lymph nodes and saliva than people without MS.

What They Found

Researchers studied lymph nodes (small immune centers) deep in the neck. They found more memory B cells (immune cells that remember past infections) in people with MS. Another type of B cell was less common in people with MS. Some B cells resembled cells with an active Epstein-Barr virus infection. The researchers also found more viral DNA in neck lymph nodes and more virus in saliva from people with MS.

Who Should Care and Why

This study included people newly diagnosed with MS who had not started treatment. It also included people without MS for comparison. Researchers studied immune cells from lymph nodes deep in the neck. They also measured Epstein-Barr virus in saliva. The findings show differences between the groups, but do not explain what caused them.

Important Considerations

You cannot tell from this study whether the virus caused the immune cell changes. The abstract does not give the number of people studied. It does not show whether these findings predict how your MS will change.

AI-generated summary — for informational purposes only, not medical advice

Categories:

Early Research

Whether you’ve recently been diagnosed with Multiple Sclerosis (MS) or are seeking to broaden your understanding of this complex, neurodegenerative disease, navigating the latest research can feel overwhelming. Studies published in respected medical journals like Science immunology often range from early-stage, exploratory work to advanced clinical trials. These evidence-based findings help shape new disease-modifying therapies, guide symptom management techniques, and deepen our knowledge of MS progression.

However, not all research is created equal. Some clinical research studies may have smaller sample sizes, evolving methodologies, or limitations that warrant careful interpretation. For a more comprehensive, accurate understanding, we recommend reviewing the original source material—accessible via the More Details section above—and consulting with healthcare professionals who specialize in MS care.

By presenting a wide range of MS-focused studies—spanning cutting-edge treatments, emerging therapies, and established best practices—we aim to empower patients, caregivers, and clinicians to stay informed and make well-informed decisions when managing Multiple Sclerosis.

Back to News